Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • ascls.org
    • ascls.org

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society for Clinical Laboratory Science
  • ascls.org
    • ascls.org
  • My alerts
  • Log in
  • My Cart
American Society for Clinical Laboratory Science

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • Follow ASCLS on Twitter
  • Visit ASCLS on Facebook
  • Follow ASCLS on Instagram
  • RSS Feed
Research ArticleDialogue and Discussion

Waived Testing

Kathy Hansen and Don Lavanty
American Society for Clinical Laboratory Science January 2002, 15 (1) 4-5; DOI: https://doi.org/10.29074/ascls.15.1.4
Kathy Hansen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Don Lavanty
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

  1. Kathy Hansen
  2. Don Lavanty

Extract

The Government Affairs Committee of ASCLS has made it a high priority to understand and attempt to influence the process of test categorization under the Clinical Laboratory Improvement Amendments (CLIA) regulations. The regulations, published in 1992, classify tests as high complexity, moderate complexity, waived, and provider performed microscopic (PPM). The latter two categories of tests are unregulated, in the sense that laboratories that perform them are not inspected and need not perform and report proficiency testing. The Center for Medicare and Medicaid Services (CMS, formerly HCFA) does have the authority to inspect waived and PPM laboratories if it has reason to suspect that they are performing tests beyond the scope of their certificate, or are not following manufacturers' instructions in performing the tests.

Waived testing has been the subject of many newsletter articles and conference presentations recently as concerns about the quality of testing and patient safety have been raised. These concerns have fallen into two areas:

  • How are tests classified as waived and do they perform reliably?

  • Are the laboratories that do waived tests performing them correctly? There is recent news on both of these fronts.

WHAT IS A WAIVED TEST?Two sets of criteria exist for evaluating waived tests, depending upon whether they are intended for home use or for diagnostic use, such as in a physician office laboratory. Responsibility for test categorization belongs to the Food and Drug Administration (FDA).

The evaluation criteria for waived tests for diagnostic use are adequate. The FDA has announced that it…

  • © Copyright 2002 American Society for Clinical Laboratory Science Inc. All rights reserved.
PreviousNext
Back to top

In this issue

American Society for Clinical Laboratory Science: 15 (1)
American Society for Clinical Laboratory Science
Vol. 15, Issue 1
Winter 2002
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Society for Clinical Laboratory Science.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Waived Testing
(Your Name) has sent you a message from American Society for Clinical Laboratory Science
(Your Name) thought you would like to see the American Society for Clinical Laboratory Science web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Waived Testing
Kathy Hansen, Don Lavanty
American Society for Clinical Laboratory Science Jan 2002, 15 (1) 4-5; DOI: 10.29074/ascls.15.1.4

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Waived Testing
Kathy Hansen, Don Lavanty
American Society for Clinical Laboratory Science Jan 2002, 15 (1) 4-5; DOI: 10.29074/ascls.15.1.4
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Dialogue and Discussion

  • Hail and Farewell
  • Response to Fall 2011 Article: Clinical Molecular Testing: Subspecialty, Entry-level or Specialist Certification
  • A Rose by Any Other Name is a … Dandelion?
Show more Dialogue and Discussion

Washington Beat

  • Challenges in Laboratory Coding 2015
  • The Saga of Health Care Reform
  • The 111th Congress and Health Care Reform
Show more Washington Beat

Similar Articles

© 2025 The American Society for Clinical Laboratory Science

Powered by HighWire